New Era of DIEP With Minimally Invasive Mastectomy
Status
Conditions
Treatments
Details and patient eligibility
About
The free deep inferior epigastric artery perforator (DIEP) flap is the gold standard in autologous breast reconstruction. Asian patients often present with a smaller body mass index with relatively insufficient tissue. To restore appropriate symmetry, a larger flap inset ratio must be transferred. Supercharging of the second vein or inclusion of bilateral pedicle is commonly required. Current paradigm shifts in mastectomy has also resulted in more minimally invasive surgeries (MIS) espousing smaller lateral incisions, leading to a significant change in available recipient vessels. This study aimed to demonstrate our experience in changing strategies of DIEP flaps following the evolution of mastectomy techniques.
Between October 2008 and March 2022, retrospective data was gathered for 278 patients who underwent breast reconstruction surgery utilizing DIEP flaps by a single plastic surgeon. These patients were divided into two distinct groups based on their operation dates, with November 2018 marking a pivotal moment when the first MIS was introduced.
Enrollment
Sex
Volunteers
Inclusion criteria
- All patients who underwent breast reconstruction procedures with DIEP flaps from October 2008 to March 2022.
- Patients who have a minimum follow-up duration of six months post-reconstruction.
Exclusion criteria
- Patients who did not meet the six-month follow-up duration was excluded from the study.
Trial design
278 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal